Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
Bridgewater Associates’ Ray Dalio pointed to Eli Lilly’s progress after the U.S. Food and Drug Administration approved a new dosing regimen, according to a report carried by Yahoo Finance.
THE APEX TIMES
THE APEX TIMES
The company says it will invest heavily in a new data-center campus in Montgomery County, Missouri, and it is also exploring ways to sell its custom Trainium AI processors to customers running their own infrastructure.
THE APEX TIMES
A CNBC segment on June 18, 2026 featured SLB’s CEO discussing nearly two decades of collaboration with NVIDIA, underscoring how AI chip ecosystems are extending beyond tech and into industrial operations.
THE APEX TIMES
A new malware strain highlighted by Microsoft is designed to exploit the convenience of Ctrl+C and Ctrl+V on Windows, redirecting copied data in ways security researchers say can help criminals drain crypto wallets.
THE APEX TIMES
Intel’s stock jumped about 10% in afternoon trading after a post on Truth Social said Apple agreed to work with Intel to design and build chips in the United States, renewing investor focus on the company’s foundry ambitions and domestic chip plans.
THE APEX TIMES
A Yahoo Finance market note highlights how Eli Lilly’s sharp long-run rally has attracted traders, even as the stock’s recent performance pattern becomes a case study for short-term positioning.
THE APEX TIMES
The new executive vice president role outlines a more focused operating structure for packaging and back-end execution as Intel aims to scale advanced process ramps and deliver system-level integration for customers.
THE APEX TIMES
The company said it has appointed new leadership within Intel Foundry to accelerate both product development timelines and the execution of manufacturing plans.
THE APEX TIMES
The airline’s board of directors approved an increased cash dividend for common shareholders, continuing a shareholder-return strategy that returns cash alongside ongoing capital spending and operating costs.
